VFF - The signal in the noise
VFF - The signal in the noise
News

Novartis CEO Joins Anthropic Board as AI Firm Pushes Into Healthcare

The Information
Read original
Share
Novartis CEO Joins Anthropic Board as AI Firm Pushes Into Healthcare

Anthropic announced that Vas Narasimhan, CEO of pharmaceutical company Novartis, is joining its board of directors. The move signals Anthropic's strategic pivot toward healthcare and life sciences applications. This comes weeks after Anthropic acquired biotech startup Coefficient Bio for approximately $400 million, underscoring a deliberate expansion into the pharmaceutical and biotech sectors.

TL;DR

  • Novartis CEO Vas Narasimhan joins Anthropic's board
  • Board addition reflects Anthropic's growing focus on healthcare and life sciences
  • Follows Anthropic's $400 million acquisition of biotech startup Coefficient Bio earlier this month
  • Signals strategic positioning of Claude AI for pharmaceutical and biotech applications

Why It Matters

Anthropic is making a deliberate institutional push into healthcare, a sector with high regulatory requirements and significant AI application potential. The combination of a major pharma CEO on the board and a biotech acquisition suggests Anthropic sees healthcare as a core vertical for Claude, not a peripheral use case.

Business Impact

For operators in biotech and pharma, this signals that Anthropic is building credibility and infrastructure to serve the sector seriously. Founders considering AI partnerships or integrations should note that Anthropic now has both domain expertise (via Coefficient Bio) and executive-level pharma relationships (via Narasimhan) to support healthcare deployments.

Key Implications

  • Anthropic is diversifying revenue and application focus beyond consumer and enterprise software into regulated industries
  • Novartis gains early access to Claude capabilities tailored for pharmaceutical research, drug discovery, and regulatory workflows
  • The board appointment legitimizes Anthropic's healthcare ambitions and may accelerate adoption among other large pharma companies

What to Watch

Monitor whether Anthropic announces healthcare-specific Claude features or products in the coming months. Watch for other pharma and biotech executives joining Anthropic's board or leadership, and track whether Novartis or other major pharma firms announce Claude partnerships or integrations in drug discovery, clinical trials, or regulatory compliance.

Share
AnthropicAI for BusinessFunding & Startups

Subscribe to the newsletter

The latest stories and analysis, delivered to your inbox.

Free. No spam. Unsubscribe any time.

Related stories

Anthropic's Opus 5 Shifts AI Race to Cost Efficiency
AnthropicTrendingNews

Anthropic's Opus 5 Shifts AI Race to Cost Efficiency

Anthropic released Claude Opus 5 on Friday, positioning it as a cost-efficient alternative to its flagship Fable 5 model at half the price. The model scores higher than Fable 5 on several coding and agentic benchmarks while maintaining the same token pricing as its predecessor, Opus 4.8. The launch reflects a shift in the AI industry from raw capability competition toward economic efficiency for enterprise workflows.

by michael.nunez@venturebeat.com (Michael Nuñez)· VentureBeat AI
Anthropic Brings Voice Mode to Stronger Claude Models
AnthropicTrendingNews

Anthropic Brings Voice Mode to Stronger Claude Models

Anthropic has expanded voice mode access beyond its Haiku model to include Opus and Sonnet, its more capable AI models. The company is also integrating voice functionality into third-party apps including Gmail, Slack, and Canva. The expansion follows user demand for voice interactions on more complex business problems that Haiku was not designed to handle.

by Terrence O’Brien· The Verge AI
AMD commits $5B to Anthropic, will supply 2GW of AI chips
AnthropicTrendingNews

AMD commits $5B to Anthropic, will supply 2GW of AI chips

AMD announced a commitment of up to $5 billion in investment to Anthropic and will supply the AI company with up to 2 gigawatts of its Instinct MI450 AI GPUs using the Helios rack-scale system. The first gigawatt is scheduled for deployment in the first half of 2027. This deal expands Anthropic's infrastructure partnerships, which already include agreements with SpaceX, TeraWulf, Google, Broadcom, and Amazon.

by Emma Roth· The Verge AI
Anthropic Eyes Robotics, Talks with Physical Intelligence Confirmed
AnthropicNews

Anthropic Eyes Robotics, Talks with Physical Intelligence Confirmed

Tech blogger Robert Scoble claimed over the weekend that Anthropic was acquiring Physical Intelligence, an AI robotics software company valued at $11 billion, triggering social media speculation. Physical Intelligence's CEO denied the claim to employees, but sources confirm the two companies held early acquisition talks this spring that did not advance. The potential deal reflects broader industry interest in combining large language models with robotics to improve AI's understanding of real-world physics and spatial reasoning.

by Phoebe Liu· The Information